Prevention of cardiovascular disease is an important public health goal. Join Drs Leiter, Ridker, and Kastelein as they discuss the results of the JUPITER study which tested the hypothesis that 20 mg of rosuvastatin daily would reduce the rate of first major cardiovascular events in subjects with low LDL-C but high hsCRP

Come test your knowledge on the Pharmacologic Management of Atrial Fibrillation and see how the community has responded.

Calling all cardiologists - complete five easy questions in a survey assessing your perceptions and current clinical practice on management and treatment of patients with ACS

Join Drs Black, Oudiz and Creager as they describe general characteristics of ET receptor antagonists and their appropriate use for patients with PAH or RH. They also select appropriate treatment strategies for PAH or RH on the basis of best practices and individual patient needs.

The 2nd Annual Advisory meeting of CREATE (Cardiac Rhythm/Electrophysiology And Targeted Education), attracted an international assembly of distinguished arrhythmologists to debate key issues in the management of Atrial Fibrillation. Learn about CREATE and view the highlights of this exceptional meeting.

The RecordAF registry is a unique worldwide initiative dedicated to the improvement of the management of atrial fibrillation (AF) in day-to-day clinical practice. Join Dr Peter Kowey's presentation to learn about the design, rationale, objectives and expected outcomes of the first large-scale international prospective registry on atrial fibrillation.

Diabetes morbidity and mortality are attributed to vascular complications, both macrovascular (myocardial infarction and stroke) and microvascular (retinopathy and nephropathy). Epidemiologic data confirms a strong positive correlation between systolic blood pressure and the risk of these complications. Join our faculty as they present the results of the ADVANCE trial, the largest trial to date of patients with type 2 diabetes, which was designed to determine if tighter control of blood pressure lowering and close management of glucose levels would reduce the risk of all complications in adults with type 2 diabetes. Featuring Drs Fox, Chalmers, MacMahon, Marre, and Poulter.

By remotely connecting clinicians and patients to enable timely transmission of actionable device and patient data the LATITUDE® Patient Management System gives you the power to impact patient outcomes, giving you only the information you want — when you want it, informing you of changes in your patient's cardiac status earlier, so you can intervene earlier. With Expert Commentary form Drs Abraham, Boehmer, Gilliam and Lipman.

Join chair Dr Mohammed Balghith and experts for a case-based presentation on learning to apply the right technique and equipment for specific coronary intervention cases, and to rapidly identify complications during the intervention and act accordingly. Experts include Drs Waqar Habib, Mohamed Arafa, Mohammed Kurdi, Abdullateef Y Khoja, and Layth A Mimish.